Equitable Community Access to Pharmacist Services Act
- Sponsor
- Sen. Thune, John [R-SD]
- Committees
- Finance Committee (primary)
- Last action
- Jul 24, 2025
Bottom line
The Equitable Community Access to Pharmacist Services Act aims to increase access to basic diagnostic and treatment services by allowing pharmacists to be reimbursed by Medicare Part B for specific services, particularly during public health crises.
What it actually does
This bill expands Medicare Part B coverage to include certain "pharmacist services," specifically for the evaluation and management of individuals for testing or treatment of common respiratory illnesses like COVID-19, influenza, RSV, and strep throat, or other public health emergency-related services. It establishes a payment mechanism for these services, generally at 80% of 85% of the physician fee schedule, with a higher rate for public health emergency services, and prohibits balance billing by pharmacists.
Proponents argue
Supporters argue this bill will significantly improve patient access to essential healthcare services, especially in rural and underserved areas where physicians may be scarce. By enabling pharmacists to be reimbursed for services within their scope of practice, it leverages an existing, accessible healthcare workforce, reduces burdens on primary care, and enhances public health preparedness by making testing and treatment for common illnesses more readily available.
Opponents contend
Critics might raise concerns about potential fragmentation of care if patients receive services from pharmacists without strong integration with their primary care providers. Some may also question the cost implications for Medicare, arguing that expanding covered services could lead to increased expenditures without clear evidence of cost savings elsewhere in the healthcare system.
The bill is short and relatively focused, making it accessible for a reader to understand its core provisions within a reasonable timeframe.
Section 2(a), amending Section 1861(s)(2) and adding 1861(nnn) of the Social Security Act.
Establishes Medicare Part B Coverage for Defined Pharmacist Services
This provision adds "pharmacist services" to the list of services covered under Medicare Part B. It defines these services as those a pharmacist is legally authorized to perform under state law, including related supplies, provided they would otherwise be covered if furnished by a physician. Crucially, it specifies that these services include evaluation and management for testing or treatment of COVID-19, influenza, RSV, or strep throat, as well as services addressing public health needs during a declared emergency.
Supporters argue
Supporters argue this provision is critical for modernizing Medicare to reflect pharmacists' capabilities and accessibility. It will reduce barriers to care, especially for vulnerable populations, and improve public health outcomes by making essential services like flu and strep testing more convenient and widely available.
Critics contend
Some might argue that expanding pharmacist services without robust integration into a patient's existing care team could lead to fragmented care or missed opportunities for comprehensive health management by a primary care physician. Concerns about quality control or oversight might also be raised.
Tradeoffs
The bill balances the need for increased access to care and leveraging pharmacists' expertise against potential concerns about care coordination and the traditional physician-centric model of Medicare.
Section 2(b), amending Section 1833(a)(1) of the Social Security Act.
Establishes Payment Rates for Pharmacist Services
This provision sets the payment rates for the newly covered pharmacist services under Medicare Part B. Generally, Medicare will pay 80% of the lesser of the actual charge or 85% of the amount determined under the physician fee schedule. However, for services addressing a public health need during a declared emergency, Medicare will pay 80% of the lesser of the actual charge or 100% of the amount determined under the physician fee schedule, effectively waiving the 15% reduction for these specific services.
Section 2(c), amending Section 1842(b)(18) of the Social Security Act.
Prohibits Balance Billing for Pharmacist Services
This provision extends the existing prohibition on balance billing to pharmacist services covered under Medicare Part B. This means that pharmacists cannot charge Medicare beneficiaries more than the Medicare-approved amount for these services, ensuring that beneficiaries are only responsible for their standard coinsurance and deductibles.
Defines "collaboration" as a process where a pharmacist works with a physician or practitioner to deliver healthcare services within the pharmacist's scope, with medical direction and supervision as defined by state law or jointly developed guidelines. This is critical for how pharmacists can operate under this new coverage.
Section 2(a), adding Section 1861(nnn)(2) to the Social Security Act.
Why it matters:This is standard legislative practice to provide detailed definitions for terms used in the main operative text, ensuring clarity and legal precision.
Case for: Supporters argue this definition ensures that pharmacist services are integrated into a broader healthcare framework, maintaining patient safety and continuity of care by requiring adherence to state-specific collaboration models.
Case against: Critics might argue that requiring collaboration, especially if state laws are restrictive, could limit the intended expansion of access by creating administrative hurdles for pharmacists, potentially undermining the bill's goal of increasing accessibility.
Estimated impact: This provision will significantly influence the operational model for pharmacists providing these services, affecting how easily and broadly they can be implemented across different states.
While generally paying 80% of 85% of the physician fee schedule, the bill specifies that for services addressing a public health need during a declared public health emergency, Medicare will pay 80% of 100% of the amount determined under the payment basis under section 1848. This effectively waives the 15% reduction that applies to other pharmacist services during emergencies.
Section 2(b), amending Section 1833(a)(1) of the Social Security Act.
Why it matters:This is common legislative drafting for conditional payment adjustments, but its impact on incentivizing services during crises is significant and could be missed.
Case for: Proponents argue this enhanced payment is a crucial incentive for pharmacists to step up during public health emergencies, ensuring that they are adequately compensated for the increased demands and risks associated with such crises, thereby bolstering the nation's public health response capacity.
Case against: Critics might argue that such a payment differential could create an incentive for over-utilization of services during emergencies or that the standard payment rate should be sufficient, questioning the necessity of a higher rate for these specific circumstances.
Estimated impact: This provision could significantly increase the financial viability for pharmacies to offer critical testing and treatment services during future public health emergencies, potentially leading to broader and faster public health responses.